​

Aprea Therapeutics Ownership | Who Owns Aprea Therapeutics?

OverviewForecastRevenueFinancialsChart

Aprea Therapeutics Ownership Summary

Aprea Therapeutics is owned by 15.67% institutional investors, 19.62% insiders, and 64.71% retail investors. Aigh capital management is the largest institutional shareholder, holding 5.81% of APRE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.67% of its assets in Aprea Therapeutics shares.

APRE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAprea Therapeutics15.67%19.62%64.71%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aigh capital management370.54K5.81%$316.07K
Sphera funds management270.00K4.44%$398.25K
Nantahala capital management205.76K3.23%$175.51K
Dafna capital management137.17K2.25%$202.33K
Drw securities120.65K1.89%$102.92K
Sio capital management112.22K1.84%$165.53K
Morgan stanley77.03K1.21%$65.71K
Vanguard group58.09K0.91%$49.55K
Jane street group46.62K0.73%$39.77K
Geode capital management40.95K0.64%$34.94K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sphera funds management270.00K0.08%$398.25K
Aigh capital management370.54K0.08%$316.07K
Dafna capital management137.17K0.05%$202.33K
Sio capital management112.22K0.04%$165.53K
Nantahala capital management205.76K0.01%$175.51K
Drw securities120.65K0.00%$102.92K
Wealthcollab158.000.00%$135.00
Exome asset management---
Tower research capital llc (trc)568.00-$838.00
Princeton global asset management---

Top Buyers

HolderShares% AssetsChange
Drw securities120.65K0.00%120.65K
Jane street group46.62K-46.62K
Morgan stanley77.03K-11.22K
Bnp paribas arbitrage, snc27.33K-10.20K
Lpl financial26.05K-10.00K

Top Sellers

HolderShares% AssetsChange
Aigh capital management370.54K0.08%-168.76K
Sio capital management112.22K0.04%-167.15K
Stonepine capital management---102.24K
Vanguard group58.09K--100.15K
Exome asset management---28.97K

New Positions

HolderShares% AssetsChangeValue
Drw securities120.65K0.00%120.65K$102.92K
Jane street group46.62K-46.62K$39.77K

Sold Out

HolderChange
Citigroup-5.00
Jpmorgan chase-10.00
Princeton global asset management-100.00
Fmr-501.00
Mb, levis & associates-806.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202515-34.78%998,602-38.31%152.21%6-14.29%4-33.33%
Sep 30, 202523-1,618,851-10.83%262.99%7-12.50%650.00%
Jun 30, 202523-11.54%1,815,208-6.90%292.82%740.00%4-42.86%
Mar 31, 202526-1,949,704-6.15%322.29%5-50.00%775.00%
Dec 31, 20242618.18%2,077,3813.81%373.32%1066.67%433.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF145.28K2.67%-
Vanguard Total Stock Mkt Idx Inv142.17K2.57%-3.11K
Fidelity Extended Market Index23.92K0.21%-
Vanguard Institutional Extnd Mkt Idx Tr19.62K0.17%-
DFA US Targeted Value I7.98K0.14%-
Fidelity Total Market Index7.20K0.06%-
Dimensional US Targeted Value ETF3.52K0.06%-
Spartan Extended Market Index Pool F3.35K0.06%171.00
Spartan Extended Market Index Pool E2.95K0.05%212.00
Fidelity Series Total Market Index5.85K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 30, 2026Gilad Oren President/CEOBuy$25.01K
Jan 30, 2026Gilad Oren President/CEOBuy$21.50K
Jan 30, 2026Hamill John P. SrVP/CFO/Prin Fin & Acct OfcrBuy$4.36K
Jan 30, 2026Hamill John P. SrVP/CFO/Prin Fin & Acct OfcrBuy$5.07K
Dec 10, 2025Duey Marc-Buy$22.32K

Insider Transactions Trends

DateBuySell
2025 Q46-
2025 Q22-
2025 Q1--
2024 Q491
2024 Q2--

APRE Ownership FAQ

Who Owns Aprea Therapeutics?

Aprea Therapeutics shareholders are primarily institutional investors at 15.67%, followed by 19.62% insiders and 64.71% retail investors. The average institutional ownership in Aprea Therapeutics's industry, Biotech Stocks , is 382.11%, which Aprea Therapeutics falls below.

Who owns the most shares of Aprea Therapeutics?

Aprea Therapeutics’s largest shareholders are Aigh capital management (370.54K shares, 5.81%), Sphera funds management (270K shares, 4.44%), and Nantahala capital management (205.76K shares, 3.23%). Together, they hold 13.48% of Aprea Therapeutics’s total shares outstanding.

Does Blackrock own Aprea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aprea Therapeutics.

Who is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested?

Sphera funds management is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.08% of its assets in 270K Aprea Therapeutics shares, valued at 398.25K$.

Who is the top mutual fund holder of Aprea Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Aprea Therapeutics shares, with 2.67% of its total shares outstanding invested in 145.28K Aprea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools